Duality Advisers’s Globus Medical GMED Stock Holding History

Duality Advisers’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-23,689	Closed	-$1.27M	–	220
2024 Q1	$1.27M	Buy	23,689 +9,398	+66%	+$505K	0.13%	267
2023 Q4	$762K	Buy	14,291 +6,650	+87%	+$324K	0.08%	358
2023 Q3	$379K	Buy	+7,641	New	+$427K	0.05%	453
2023 Q2	–	Sell	-46,946	Closed	-$2.66M	–	596
2023 Q1	$2.66M	Buy	46,946 +19,071	+68%	+$1.22M	0.3%	123
2022 Q4	$2.07M	Buy	+27,875	New	+$1.9M	0.24%	149
2022 Q3	–	Sell	-13,812	Closed	-$775K	–	617
2022 Q2	$775K	Buy	+13,812	New	+$908K	0.08%	404
2021 Q4	–	Sell	-2,651	Closed	-$203K	–	576
2021 Q3	$203K	Buy	+2,651	New	+$213K	0.02%	498
2021 Q2	–	Sell	-12,588	Closed	-$776K	–	607
2021 Q1	$776K	Buy	+12,588	New	+$797K	0.07%	389
2020 Q4	–	Sell	-82,900	Closed	-$4.11M	–	621
2020 Q3	$4.11M	Buy	+82,900	New	+$4.28M	0.26%	84

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Duality Advisers's GMED Position: Q2 2024 in Review

Duality Advisers sold out of Globus Medical (GMED) in Q2 2024, closing a stake of 23,689 shares — an estimated $1.27M sold.

Duality Advisers first reported a position in GMED in Q3 2020 and held it in 9 quarters. The position peaked at $4.11M in Q3 2020. 450 funds tracked by Wall St. Rank hold GMED as of Q2 2024.

Duality Advisers reported no remaining Globus Medical position as of Q2 2024 after selling out during the quarter.
Duality Advisers sold 23,689 Globus Medical shares in Q2 2024, an estimated $1.27M.
Duality Advisers first reported a position in Globus Medical in Q3 2020 and held it in 9 quarters.
Duality Advisers's Globus Medical position peaked at $4.11M in Q3 2020.
450 funds tracked by Wall St. Rank held Globus Medical as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.